Clinical ink
Share on
CONTACT US: 1.336.714.7402


Leading Pharma Takes Control of Infectious Disease Trial With Real-Time Data

See how a rapidly deployed Lunexis eSource Ecosystem (integrated eCOA, ePRO+, DDC, and eConsent) had this trial moving in 10 weeks — read the case study!

Screen Shot 2021-09-02 at 8.52.44 AM

If you want to meet patients where they are and make data available to CROs and sponsors in real time, eliminating the majority of SDV is key. With evolving infectious disease situations, near-immediate access enables teams to respond to individual or epidemiologic developments right away. Learn about a leading pharma company’s Phase III trial for a SARS-CoV-2 prophylactic therapy in 1,000+ patients at 82 sites.

Download and Read This Resource Now